These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8897062)

  • 1. Local treatment with an antithrombotic drug reduces thrombus size in coronary and peripheral thrombosed arteries.
    Tomaru T; Nakamura F; Aoki N; Sakamoto Y; Omata M; Uchida Y
    Heart Vessels; 1996; 11(3):133-44. PubMed ID: 8897062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of thrombolysis and prevention of thrombus formation by local drug delivery with a double-occlusion balloon catheter.
    Tomaru T; Fujimori Y; Nakamura F; Aoki N; Sakamoto Y; Kawai K; Omata M; Uchida Y
    Heart Vessels; 1996; 11(3):123-32. PubMed ID: 8897061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local treatment with antithrombotic drugs can prevent thrombus formation: an angioscopic and angiographic study.
    Tomaru T; Nakamura F; Fujimori Y; Omata M; Kawai S; Okada R; Murata Y; Uchida Y
    J Am Coll Cardiol; 1995 Nov; 26(5):1325-32. PubMed ID: 7594050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin and thrombolytic effects of a new antithrombin agent: angioscopic and angiographic comparison with heparin or batroxobin.
    Tomaru T; Nakamura F; Miwa AY; Fujimori Y; Omata M; Okada R; Uchida Y
    J Interv Cardiol; 1994 Oct; 7(5):409-19. PubMed ID: 10155190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local antithrombotic therapy using a novel porous balloon catheter.
    Tomaru T; Kobayakawa N; Onitake A; Nakamura F; Morita T; Uchida Y
    Jpn Heart J; 2000 Jan; 41(1):87-95. PubMed ID: 10807533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local delivery of antithrombotic drug prevents restenosis after balloon angioplasty in atherosclerotic rabbit artery.
    Tomaru T; Fujimori Y; Morita T; Aoki N; Sakamoto Y; Nakamura F; Omata M; Uchida Y
    Jpn Circ J; 1996 Dec; 60(12):981-92. PubMed ID: 8996689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of antithrombotic effect of heparin and antithrombin in balloon-injured arteries.
    Tomaru T; Kawano HA; Tsujiuchi Y; Suzuki J; Nakajima T; Uchida Y
    Life Sci; 2005 Oct; 77(21):2611-25. PubMed ID: 16005470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive Therapy with an Antithrombotic Drug Can Prevent Reocclusion and Induce Residual Thrombus Reduction After Percutaneous Transcatheter Angioplasty of the Thrombotic Lesions.
    Kawano H; Tomaru T; Omata M; Okada R; Uchida Y
    J Thromb Thrombolysis; 1997; 4(2):293-300. PubMed ID: 10639273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
    Berry CN; Girard D; Girardot C; Lochot S; Lunven C; Visconte C
    Semin Thromb Hemost; 1996; 22(3):233-41. PubMed ID: 8836007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.
    Duval N; Lunven C; O'Brien DP; Grosset A; O'Connor SE; Berry CN
    Br J Pharmacol; 1996 Jun; 118(3):727-33. PubMed ID: 8762100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
    Imura Y; Stassen JM; Collen D
    J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of a sub-cutaneously administered novel mixed micellar formulation of argatroban in rat and rabbit models of venous thrombosis.
    Berry CN; Visconte C; Lecoffre C; Lochot S; Girard D
    Thromb Haemost; 2000 Aug; 84(2):286-90. PubMed ID: 10959702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of a direct thrombin inhibitor and a platelet glycoprotein IIb/IIIa blocking peptide facilitates and maintains reperfusion of platelet-rich thrombus with alteplase.
    Sabatine MS; Tu TM; Jang IK
    J Thromb Thrombolysis; 2000 Oct; 10(2):189-96. PubMed ID: 11005941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of arterial thrombolysis with native tissue type plasminogen activator by pretreatment with heparin or batroxobin: an angioscopic study.
    Tomaru T; Uchida Y; Nakamura F; Sonoki H; Tsukamoto M; Sugimoto T
    Am Heart J; 1989 Feb; 117(2):275-81. PubMed ID: 2492737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
    Berry CN; Girard D; Lochot S; Lecoffre C
    Br J Pharmacol; 1994 Dec; 113(4):1209-14. PubMed ID: 7889274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local drug delivery of argatroban from a polymeric-metallic composite stent reduces platelet deposition in a swine coronary model.
    Kruse KR; Crowley JJ; Tanguay JF; Santos RM; Millare DS; Phillips HR; Zidar JP; Stack RS
    Catheter Cardiovasc Interv; 1999 Apr; 46(4):503-7. PubMed ID: 10216025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study.
    Jang IK; Brown DF; Giugliano RP; Anderson HV; Losordo D; Nicolau JC; Dutra OP; Bazzino O; Viamonte VM; Norbady R; Liprandi AS; Massey TJ; Dinsmore R; Schwarz RP
    J Am Coll Cardiol; 1999 Jun; 33(7):1879-85. PubMed ID: 10362188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
    Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
    J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of napsagatran (Ro 46-6240), a new synthetic thrombin inhibitor and of heparin in a canine model of coronary artery thrombosis: comparison with an ex vivo annular perfusion chamber model.
    Roux S; Tschopp T; Baumgartner HR
    J Pharmacol Exp Ther; 1996 Apr; 277(1):71-8. PubMed ID: 8613969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic effect of argatroban on the pial vessels of the rat: a study with He-Ne laser-induced thrombus formation.
    Sasaki Y; Morii S; Yamashita T; Yamamoto J
    Haemostasis; 1993; 23(2):104-11. PubMed ID: 8365687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.